2022 28 (1) “invest to end tb

HIGHLIGHTS

  • who: Ruwanpura A. JCCPSL and colleagues from the Kotelawala Defense University, Sri Lanka have published the paper: 2022 28 (1) "Invest to End TB, in the Journal: (JOURNAL) of 19/01/2022

SUMMARY

    In 1921, the Bacillus Calmette-Guerin (BCG) vaccine was first administered to a patient. In 2019, 2 billion people were infected with TB. An estimated 10 million people developed active TB. Each year, 1.5 million lives are lost to this deadly yet curable disease. Emergence of multi drug resistant TB contributes to the high death toll. Contacts of TB . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?